Loading
Loading…
Loading…
Eligibility, documents, scope, Go/No-Go checksEligibility, required documents, scope of work and Go/No-Go checks for this tender, in one click.
Tender Value
₹15,439
EMD Value
Exempted
Closing Date
19 Oct 2026, 3:00 pm
Eligibility, documents, scope, Go/No-Go checksEligibility, required documents, scope of work and Go/No-Go checks for this tender, in one click.
Published by the portal on this tender, for queries and grievance redressal.
Acetazolamide Tablets (V2) (Q2)
Clindamycin Injection (Q2)
Amitriptyline Tablets (V2) (Q2)
Baclofen Tablets (V2) (Q2)
Heparin Injection (Q2) ( ( 3 3 ))
9979853
GEM/2026/B/8112489
Two Packet Bid
Acetazolamide Tablets (V2)
Ernakulam, Kerala
Item wise evaluation
PRODUCT
7 documents required · 7 mandatory
3 yrs
₹31
₹1 L
80%
| Item | Delivery Location | Qty | Delivery |
|---|---|---|---|
| Acetazolamide Tablets (V2) (Q2) | Madhu PR 683501,ESIC HOSPITAL, PATHALAM JUNCTION, UDYOGAMANDALP.O., ERNAKULAM | 100 | 45 days |
| Clindamycin Injection (Q2) | Madhu PR 683501,ESIC HOSPITAL, PATHALAM JUNCTION, UDYOGAMANDALP.O., ERNAKULAM | 150 | 45 days |
| Amitriptyline Tablets (V2) (Q2) | Madhu PR 683501,ESIC HOSPITAL, PATHALAM JUNCTION, UDYOGAMANDALP.O., ERNAKULAM | 8,000 | 45 days |
| Baclofen Tablets (V2) (Q2) | Madhu PR 683501,ESIC HOSPITAL, PATHALAM JUNCTION, UDYOGAMANDALP.O., ERNAKULAM | 6,000 | 45 days |
| Heparin Injection (Q2) ( ( 3 3 )) | Madhu PR 683501,ESIC HOSPITAL, PATHALAM JUNCTION, UDYOGAMANDALP.O., ERNAKULAM | 20 | 45 days |
Exempted
Yes
9 Oct 2026
9 Oct 2026
20 Oct 2026
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_9979853.pdf
GEM_BID • 0.32 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .